Potassium supplementation in ritodrine-induced hypokalemia

K. Reed Peters, Barbara J. Hurlbert, Jerry D. Edelman, Robert C. Goodlin

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Acute hypokalemia occurs during infusion of β2 agonists for tocolysis. This study examines the efficacy of supplemental potassium in treating this hypokalemia. Four groups of dogs were anesthetized and given lactated Ringer's solution (group I), potassium chloride (group II), ritodrine hydrochloride (group III), and ritodrine plus potassium (group IV). Arterial blood gases, pH, and serum and urinary electrolytes were measured. Results were analyzed by an analysis of variance. Serum potassium fell in groups I and III, rose in group II, and remained stable in group IV. Urinary potassium levels in groups that received ritodrine (III and IV) were not different from control levels. Potassium given with ritodrine will prevent hypokalemia. However, the risks of hyperkalemia exist if vigorous replacement is undertaken. There were no dysrhythmias and no adverse effects in any of the hypokalemic animals. Therefore, the routine administration of potassium is not advocated even in obstetric patients who undergo general anesthesia.

Original languageEnglish (US)
Pages (from-to)393-396
Number of pages4
JournalAmerican Journal of Obstetrics and Gynecology
Issue number4
StatePublished - Jun 15 1984

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Potassium supplementation in ritodrine-induced hypokalemia'. Together they form a unique fingerprint.

Cite this